Ionis Pharmaceuticals, Inc. (IONS)
NASDAQ: IONS · Real-Time Price · USD
43.45
+0.42 (0.98%)
Aug 4, 2025, 4:00 PM - Market closed
Everbridge Stock Forecast
Stock Price Forecast
The 14 analysts that cover Everbridge stock have a consensus rating of "Buy" and an average price target of $57.79, which forecasts a 33.00% increase in the stock price over the next year. The lowest target is $37 and the highest is $77.
Price Target: $57.79 (+33.00%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Everbridge stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 7 | 7 | 7 | 5 |
| Buy | 7 | 6 | 4 | 4 | 4 | 5 |
| Hold | 5 | 6 | 6 | 6 | 5 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 19 | 19 | 18 | 18 | 17 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Raymond James | Raymond James | Strong Buy Maintains $60 → $64 | Strong Buy | Maintains | $60 → $64 | +47.30% | Jul 31, 2025 |
| Morgan Stanley | Morgan Stanley | Hold → Buy Upgrades $55 → $62 | Hold → Buy | Upgrades | $55 → $62 | +42.69% | Jul 31, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $50 → $65 | Strong Buy | Maintains | $50 → $65 | +49.60% | Jul 31, 2025 |
| Barclays | Barclays | Hold → Buy Upgrades $51 → $57 | Hold → Buy | Upgrades | $51 → $57 | +31.19% | Jul 1, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | +15.07% | Jun 26, 2025 |
Financial Forecast
Revenue This Year
770.05M
from 705.14M
Increased by 9.21%
Revenue Next Year
880.57M
from 770.05M
Increased by 14.35%
EPS This Year
-3.15
from -3.04
EPS Next Year
-3.22
from -3.15
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 952.4M | 1.4B | 1.6B | ||
| Avg | 770.1M | 880.6M | 1.2B | ||
| Low | 701.0M | 608.6M | 395.9M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 35.1% | 76.5% | 84.3% | ||
| Avg | 9.2% | 14.4% | 36.6% | ||
| Low | -0.6% | -21.0% | -55.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -2.43 | -1.47 | -0.13 | ||
| Avg | -3.15 | -3.22 | -1.63 | ||
| Low | -3.88 | -4.82 | -3.37 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.